Cytokines associated with Inflammatory Bowel Disease

ISSN: 1875-631X (Online)
ISSN: 1573-3955 (Print)

Volume 12, 2 Issues, 2016

Download PDF Flyer

Current Immunology Reviews

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Cecil Czerkinsky
Institut de Pharmacologie Moleculaire et Cellulaire
660 Route des Lucioles
Valbonne, 06560

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Cytokines associated with Inflammatory Bowel Disease

Current Immunology Reviews, Volume 9 (E-pub ahead of print)

Author(s): Gabriela Fonseca-Camarillo and Jesús K Yamamoto-Furusho.

Affiliation: Head of IBD Clinic, Department of Gastroenterology Instituto Nacional de Ciencias Médicas y Nutrición Vasco de Quiroga #15. Col. Sección XVI, Tlalpan, CP 14000 México.


The Inflammatory Bowel Disease (IBD) comprises two forms Ulcerative Colitis (UC) and Crohn's Disease (CD). The intestinal inflammation in IBD is controlled by a complex interplay of innate and adaptive immune mechanisms. Evidence indicates that a dysregulation of these mechanisms in the mucosal immunity of the gut in IBD patients causes an overproduction of cytokines leading to an uncontrolled intestinal inflammation. The discovery of novel cytokines in the IBD is important in order to understand the mechanisms that are involved in the gut mucosal immunity, as well as the design of new therapeutic targets focused on the production of specific cytokine inhibitors.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 9
First Page: 1
Page Count: 1
DOI: 10.2174/157339551130900009
ImmunogenicityGlobal Biotechnology Congress 2016Drug Discovery and Therapy World Congress 2016

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science